ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Trédan, O; Ménétrier-Caux, C; Ray-Coquard, I; Garin, G; Cropet, C; Verronèse, E; Bachelot, T; Rebattu, P; Heudel, P E; Cassier, P; Chabaud, S; Croughs, T; Dupont, P; Cadore, A C; Clapisson, G; Delgado, A; Bardin-dit-Courageot, C; Rigal, C; N’Kodia, A; Gilles-Afchain, L; Morre, M; Pérol, D; Blay, J Y; Caux, C
Annals of Oncology. 2018.